Table 2.

Effects of PSPE on serum insulin and serum lipids in diabetic rats

Group	Serum insulin (μIU/ml)	TC (mg/dl)	TG (mg/dl)	LDL-C (mg/dl)	HDL-C (mg/dl)
NCG	8.51±0.34	87.13±2.97	95.45±2.97	14.83±0.86	53.83±0.65
DCG	16.91±0.42##	137.12±2.51##	158.65±3.86##	54.17±1.33##	26.44±0.87##
MG	11.75±0.55*	97.28±3.34**	103.74±2.55**	21.87±0.84**	44.75±0.62**
PSPE 50	12.08±0.43*	107.33±2.76**	123.82±1.97**	23.64±0.92*	40.16±0.74**
PSPE 100	13.16±0.41*	103.43±3.21**	118.08±2.87**	18.67±0.76**	41.53±0.62**
PSPE 200	14.45±0.34*	100.62±2.64**	109.59±2.13**	18.36±0.63**	42.36±0.87**

Results are expressed as the mean±SD (n=7). TC: total cholesterol; TG: triglycerides; LDL-C: low density lipoprotein-cholesterol; HDL-C: high density lipoprotein-cholesterol; NCG: normal control group; DCG: diabetic control group; MG: diabetic rats treated with Met (200 mg/kg); PSPE 50: diabetic rats treated with PSPE (50 mg/kg, oral); PSPE 100: diabetic rats treated with PSPE (100 mg/kg, oral); PSPE 200: diabetic rats treated with PSPE (200 mg/kg, oral).

^## P<0.01, compared with NCG;

^* P<0.05,

^** P<0.01, compared with DCG